Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Sept. 29, 2024
Circulating
tumour
cells
(CTCs),
derived
from
primary
tumours,
play
a
pivotal
role
in
cancer
metastasis
by
migrating
into
the
peripheral
bloodstream.
These
are
paramount
clinical
research,
serving
as
early
diagnostic
markers
for
metastatic
cancer.
Analysing
CTC
counts
and
their
biomarker
characteristics
can
provide
invaluable
insights
identification,
profiling,
capabilities.
However,
rarity
diverse
nature
of
CTCs
bloodstream
present
significant
challenges
to
isolation
detection,
especially
initial
stages
metastasis.
Recent
advancements
nanotechnology
have
led
development
innovative
separation
detection
methods.
This
review
focuses
on
applying
nanoparticles,
nanomaterials,
microfluidic
platforms
simplify
CTCs.
The
infusion
this
field
marks
crucial
turning
point,
enabling
necessary
progress
advance
research.
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: Dec. 1, 2024
Cancer
has
a
high
mortality
rate
across
the
globe,
and
tissue
biopsy
remains
gold
standard
for
tumor
diagnosis
due
to
its
level
of
laboratory
standardization,
good
consistency
results,
relatively
stable
samples,
accuracy
results.
However,
there
are
still
many
limitations
drawbacks
in
application
tumor.
The
emergence
liquid
provides
new
ideas
early
prognosis
Compared
with
biopsy,
advantages
treatment
various
types
cancer,
including
non-invasive,
quickly
so
on.
Currently,
detection
received
widely
attention.
It
is
now
undergoing
rapid
progress,
it
holds
significant
potential
future
applications.
Around
now,
biopsies
encompass
several
components
such
as
circulating
cells,
DNA,
exosomes,
microRNA,
RNA,
platelets,
endothelial
cells.
In
addition,
advances
identification
indicators
have
significantly
enhanced
possibility
utilizing
clinical
settings.
this
review,
we
will
discuss
application,
challenges
some
common
tumors
from
perspective
diverse
systems
tumors,
look
forward
development
prospects
field
cancer
treatment.
Cells,
Journal Year:
2023,
Volume and Issue:
12(22), P. 2590 - 2590
Published: Nov. 8, 2023
Circulating
tumor
cells
(CTCs)
have
emerged
as
pivotal
biomarkers
with
significant
predictive
and
prognostic
implications
in
solid
tumors.
Their
presence
peripheral
blood
offers
a
non-invasive
window
into
the
dynamic
landscape
of
cancer
progression
treatment
response.
This
narrative
literature
review
synthesizes
current
state
knowledge
surrounding
multifaceted
role
CTCs
predicting
clinical
outcomes
informing
prognosis
across
spectrum
malignancies.
delves
evolving
CTC-based
research,
emphasizing
their
potential
early
indicators
disease
recurrence,
metastatic
potential,
therapeutic
resistance.
Moreover,
we
underscored
nature
for
personalized
medicine.
A
descriptive
critical
analysis
CTC
detection
methodologies,
relevance,
associated
challenges
is
also
presented,
focus
on
recent
advancements
emerging
technologies.
Furthermore,
examine
integration
liquid
biopsies
practice,
highlighting
guiding
decisions,
monitoring
efficacy,
facilitating
precision
oncology.
highlights
transformative
impact
management
tumors
by
promoting
deeper
understanding
relevance
advancing
field
Cancers,
Journal Year:
2023,
Volume and Issue:
15(7), P. 2185 - 2185
Published: April 6, 2023
Over
the
last
decade,
liquid
biopsy
has
gained
much
attention
as
a
powerful
tool
in
personalized
medicine
since
it
enables
monitoring
cancer
evolution
and
follow-up
of
patients
real
time.
Through
minimally
invasive
procedures,
provides
important
information
through
analysis
circulating
tumour
cells
(CTCs)
tumour-derived
material,
such
DNA
(ctDNA),
miRNAs
(cfmiRNAs)
extracellular
vehicles
(EVs).
CTC
already
had
an
impact
on
prognosis,
detection
minimal
residual
disease
(MRD),
treatment
selection
patients.
Numerous
clinical
trials
nowadays
include
arm.
is
now
exponentially
expanding
field
almost
all
types
solid
cancers.
Functional
studies,
mainly
based
CTC-derived
cell-lines
explants
(CDx),
provide
insights
into
metastatic
process.
The
purpose
this
review
to
summarize
latest
findings
significance
CTCs
for
management
patients,
covering
four
years.
This
focuses
providing
comprehensive
overview
breast,
prostate
non-small-cell
lung
cancer.
unique
potential
single-cell
understanding
metastasis
biology,
importance
quality
control
standardization
methodologies
used
field,
also
discussed.
Case Studies in Chemical and Environmental Engineering,
Journal Year:
2024,
Volume and Issue:
9, P. 100694 - 100694
Published: March 18, 2024
In
This
study,
three
new
surface-modified
antibacterial
and
anticorrosive
nanocomposites
(zinc
Phosphate-
Polyvinyl
Pyrrolidone,
Zinc
Pyrrolidone/Hydroxy
Apatite
Apatite/Alginate)
were
synthesized
in
low-temperature
by
facile
efficient
method.
We
crosslink
Alg
with
Zn2+
Ca2+
to
make
it
insoluble
enhancing
of
their
physical
biological
properties
Apatite/Alginate).
Nanocrystals
characterized
(XRD),
(FT-IR),
(EDX),
(SEM)
(TEM).
the
TEM
image
showed
that
core
shell
nanocrystal
had
good
dispersion
a
particle
size
8–36,
12–38
10–45
nm,
respectively.
Antibacterial
rate
Apatite/Alginate
NPs
reached
near
100%.
To
analyze
EIS
results
obtained
from
equivalent
circuits,
parameters
such
as
Rct,
CPEdl,
Rf,
n,
CPEf,
Rt
extracted.
Nyquist
diagrams
demonstrated
sample
better
protection
than
Pyrrolidone
sample,
at
all
immersion
time.
The
phase
angle
(-θ
11°/96
h)
was
greater
value
compared
Alginate
10°/96
4.2°/96
h),
indicating
transition
capacitive
inductive
behavior
longer
times.
Cancer Genetics,
Journal Year:
2024,
Volume and Issue:
288-289, P. 32 - 39
Published: Sept. 3, 2024
Neuroblastoma
is
a
paediatric
malignancy
of
the
sympathoadrenal
or
Schwann
cells
derived
from
neural
crest.
Risk
stratification
in
neuroblastoma
informed
by
MYCN
amplification,
age,
stage,
ploidy,
and
segmental
chromosomal
alterations.
High-risk
cases
bear
dismal
overall
survival.
A
panel
pathology
imaging
modalities
are
utilised
for
diagnosis,
while
treatment
strategies
depend
on
risk
group.
Despite
this,
relapse
can
occur
50%
high-risk
patients
remission
post-treatment.
Liquid
biopsies
typically
comprise
sampling
peripheral
blood
attractive
since
they
less
invasive
than
surgical
tumour
tissue
biopsies.
retrieve
circulating
DNA
RNA
released
tumours
addition
to
cells.
These
biological
materials
be
analyse
genetic
Monitoring
tumour-derived
molecular
information
assist
diagnostics,
targeted
therapy
selection,
reflecting
minimal
residual
disease,
relapse,
recurrence.
This
study
aims
review
latest
research
liquid
disease
assessing
efficacy,
recurrence
neuroblastoma.
deeper
understanding
application
could
inform
future
prospective
clinical
trials,
time,
facilitate
their
routine
implementation
practice.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(16), P. 8594 - 8594
Published: Aug. 6, 2024
Liquid
biopsy,
a
noninvasive
diagnosis
that
examines
circulating
tumor
components
in
body
fluids,
is
increasingly
used
cancer
management.
An
overview
of
relevant
literature
emphasizes
the
current
state
liquid
biopsy
applications
care.
Biomarkers
particularly
DNA
(ctDNA),
RNAs
(ctRNA),
cells
(CTCs),
extracellular
vesicles
(EVs),
and
other
components,
offer
promising
opportunities
for
early
diagnosis,
treatment
selection,
monitoring,
disease
assessment.
The
implementation
precision
medicine
has
shown
significant
potential
various
types,
including
lung
cancer,
colorectal
breast
prostate
cancer.
Advances
genomic
molecular
technologies
such
as
next-generation
sequencing
(NGS)
digital
polymerase
chain
reaction
(dPCR)
have
expanded
utility
enabling
detection
somatic
variants
actionable
alterations
tumors.
also
demonstrated
predicting
responses,
monitoring
minimal
residual
(MRD),
assessing
heterogeneity.
Nevertheless,
standardizing
techniques,
interpreting
results,
integrating
them
into
clinical
routine
remain
challenges.
Despite
these
challenges,
implications
management,
offering
dynamic
approach
to
understanding
biology
guiding
personalized
strategies.
Cancers,
Journal Year:
2024,
Volume and Issue:
16(6), P. 1213 - 1213
Published: March 20, 2024
Circulating
tumor
cells
(CTCs)
are
released
from
the
primary
and
metastatic
intravasate
into
blood
or
lymphatic
vessels,
where
they
transported
to
distant
sites
act
as
seeds
that
initiate
cancer
metastases
development
of
further
lesions.
Recent
advances
in
CTC
research
have
shown
their
relevance
prognostic
markers
for
early
disease
detection,
predictive
biomarkers
relapse,
response
medical
intervention
therapy.
The
rapidly
evolving
landscape
biology
has
opened
new
avenues
understanding
progression,
metastasis,
treatment
response.
Additionally,
translating
these
findings
clinical
applications
holds
promise
improving
diagnostics,
prognosis,
personalized
therapeutic
strategies.
This
review
discusses
significance
CTCs
associated
challenges.
We
explore
recent
developments
detection
characterization
implications
practice.
ACS Omega,
Journal Year:
2025,
Volume and Issue:
10(7), P. 6306 - 6322
Published: Feb. 11, 2025
Enriching
and
isolating
circulating
tumor
cells
(CTCs)
have
attracted
significant
interest
due
to
their
important
role
in
early
cancer
diagnosis
prognosis,
allowing
for
minimally
invasive
approaches
providing
vital
information
about
metastasis
at
the
cellular
level.
This
review
comprehensively
summarizes
recent
developments
microfluidic
devices
CTC
enrichment
isolation.
The
advantages
limitations
of
several
are
discussed,
design
specifications
highlighted.
We
also
developed
a
set
methodologies
rules
label-free
microfluidics
such
as
spiral,
deterministic
lateral
displacement
(DLD)
dielectrophoresis
(DEP)
allow
researchers
develop
systematically
effectively,
promoting
rapid
research
on
design,
fabrication,
experimentation.